CC - Bloomberg reports that Chinese BGM maker, Sinocare offers ~$1 billion to acquire Bayer Diabetes Care –
According to Bloomberg, Chinese BGM maker Sinocare and China-based investment bank Citic Securities have proposed to acquire Bayer Diabetes Care for ~$1 billion. The short article cites confidential sources, and reports that Sinocare is competing with Panasonic Healthcare, who was linked to acquisition rumors back in February. As a reminder, Bayer CEO Mr. Marjin Dekkers said in the company’s 4Q14 call that the future of the Diabetes Care devices business was “a situation in flux.” Management stressed at the time that the business is a cash-flow generator; still, given the sales declines in the past 18 months, profitability likely continues to shrink and after the dramatic Medicare price pricing pressure (thanks CMS!), there are certainly few if any funds left for innovation. We wonder if CMS perceives this as better off for patients? For some without insurance, having access to lower price strips is a positive – most are at a similar or higher co-pay and the payer is paying much less. Much of the news surrounding this arena continues to be speculation, and we will look for more concrete information in the near to mid term. Bayer did not respond to our request for comment.